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Available online 7 October 2011Abstract Disease-specific induced pluripotent stem cells (iPSC) allow unprecedented experimental platforms for basic
research as well as high-throughput screening. This may be particularly relevant for neuropsychiatric disorders, in which the
affected neuronal cells are not accessible. Keratinocytes isolated from hair follicles are an ideal source of patients' cells
for reprogramming, due to their non-invasive accessibility and their common neuroectodermal origin with neurons, which
can be important for potential epigenetic memory. From a small number of plucked human hair follicles obtained from
two healthy donors we reprogrammed keratinocytes to pluripotent iPSC. We further differentiated these hair
follicle-derived iPSC to neural progenitors, forebrain neurons and functional dopaminergic neurons.
This study shows that human hair follicle-derived iPSC can be differentiated into various neural lineages, suggesting this
experimental system as a promising in vitro model to study normal and pathological neural developments, avoiding the invasiveness
of commonly used skin biopsies.
© 2011 Elsevier B.V. All rights reserved.Abbreviations: HF, hair follicle; iPSC, induced pluripotent stem
cells; ORS, outer root sheath; HPLC, high performance liquid
chromatography.
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doi:10.1016/j.scr.2011.09.003Introductionrved.Reprogramming of somatic cells into induced pluripotent stem
cells (iPSC) and differentiating them to neuronal lineage is a
new powerful technology that could offer an attractive tool
to model neurodevelopmental disorders. Neuropsychiatric dis-
orders, as many other complex disorders, necessitate cellular
models with relevance to their underlying biological mecha-
nisms and pharmacotherapy. The biological basis of psychiatric
disorders is still enigmatic, despite tremendous advances in
Induced pluripotent stem cells from hair follicles 135science and medicine. Several lines of evidence support a neu-
rodevelopmental, multifactorial etiology in psychiatric dis-
eases, specifically in schizophrenia (Jaaro-Peled et al., 2009),
suggesting embryonic insults that impact brain developmental
events. However, in the absence of consistent biological
markers for these disorders, diagnosis still relies on subjective
assessment of a cluster of signs and symptoms. Currently, pe-
ripheral or post-mortem brain human samples are available
for the biological research of neuropsychiatric diseases, mark-
edly hampering molecular studies (Stevens et al., 2010). The
advantage of iPSC as a tool to study neuropsychatric disorders
is that they can be largely expanded, they express the individ-
ual genome (and possibly epigenome), and can be differentiat-
ed into a specific neuronal lineage, thereby enabling the study
of neurodevelopmental processes in vitro (Kiskinis and Eggan,
2010).
One of the main obstacles in human studies is sample ac-
quisition. Human iPSC lines are usually produced from fibro-
blasts isolated from skin biopsies, a traumatic invasive
procedure demanding local anesthesia and medical follow-
up. Hair follicle (HF) plucking, however, is simple, painless
and non-invasive alternative procedure. Moreover, the HF-
keratinocytes, similar to neurons are derived from the same
ectodermal embryonic layer, and thus, besides carrying the
same genetic load, could retain the same epigenetic alter-
ations during early development. Aasen et al. have shown
that skin and HF keratinocytes could be reprogrammed into
iPSC (Aasen et al., 2008; Aasen and Belmonte, 2010). In the
present study we confirmed the feasibility of this approach
and improved it by using 1) a polycistronic lentival vector,
2) exogenous inhibitors and 3) stored hairs. Moreover, we
show that iPSC from HF (HF-iPSC) have potential to give neu-
ral progenitors and functional neurons. We propose a cellularA B
C D
Figure 1 Derivation of iPSC from hair follicles. (A) A hair follicle i
that contains keratinocytes. (B) Keratinocyte colony 10 days after iso
following infection with GFP-lentivirus. (D) Typical iPSC colony derimodel of iPSC obtained from few hair follicles plucked from
the scalp region, utilizing it as a novel source for in vitro neu-
ral commitment to model neurodevelopmental disorders.Results and discussion
We found that as few as ten HF in anagen phase, identified
by the presence of the outer root sheath, were sufficient
to obtain keratinocytes for reprogramming (Fig. 1A). Nota-
bly, HF can be stored for at least 48 h in plain medium at
room temperature without a decrease in cell recovery,
allowing shipments worldwide. Keratinocytes were de-
tached by trypsin treatment from HF and typical keratino-
cyte colonies appeared 7–10 days later (Fig. 1B) (Limat and
Noser, 1986) for all healthy or diseased donors that we test-
ed. Early passage keratinocytes were infected with lentiviral
particles expressing the polycistronic plasmid STEMCCA
(OCT4, SOX2, KLF4 and c-MYC), which allows simultaneous
delivery of the 4 genes with only one integration site, maxi-
mizing reprogramming efficiency (Somers et al., 2010). A
GFP control virus confirmed high infection rate of primary
keratinocytes (Fig. 1C). We found that reprogramming was
increased by 3.5 fold (p=0.04) with the use of SB431542,
CHIR99021, Parnate and PS48 (Zhu et al., 2010). Several col-
onies with typical hES morphology (defined border, high nu-
clei/cytoplasm ratio and prominent nucleoli) were obtained
and expanded individually (Fig. 1D).
Pluripotency of HF-derived iPSC from 2 healthy individ-
uals (HF-iPSC-1 and HF-iPSC-2) was confirmed by the expres-
sion of the pluripotency markers Pou5F1 (Oct3/4), SOX2,
NANOG and DNMT3B (Fig. 2A) as well as by TRA-1-81, SSEA-n anagen phase, the arrow indicates the outer root sheath layer
lation from hair follicles. (C) A GFP-positive keratinocyte colony
ved from HF keratinocytes. Scale bars: 100 μm.
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Figure 2 Pluripotency of HF-iPSC. (A) Expression of the pluripotency genes, Oct4. Sox2, Nanog and Dnmt3b determined by qRT-PCR
in two iPSC lines (HF-iPSC-1 and-2). Human embryonic stem cells (hES) and HF keratinocytes were used as positive and negative con-
trol respectively. Gene expression levels were calculated relatively to their expression in hES. Primers for Oct3/4 and Sox2 recognize
endogenous and exogenous forms. (B) HF-iPSC-1 was stained for cell surface expression of TRA-1-81 and SSEA-4 and for alkaline phos-
phastase activity. Identical results were obtained for HF-iPSC-2 (data not shown). (C) Transcriptional profile of HF-iPSC was analyzed
by PluriTest assay. (i) PluriTest results plotted in density distribution for previously referenced pluripotent cells (red cloud) and so-
matic cells (blue cloud) (Müller et al., 2011), HF-iPSC and keratinocytes. (ii) Hierarchical clustering of HF-iPSC lines HF-iPSC-1 and 2
clones of HF-iPSC-2, keratinocytes, hES (WA09) and iPSC derived from fibroblasts sampled from two individuals (HDF86iPS6 and
HDF90iPS2). Samples were run in duplicates. (D) Embryoid bodies from HF-iPSC lines (i). Germ layer markers (CD31-mesoderm,
K14-ectoderm and AFP-endoderm) determined by qRT-PCR at day 21. Expression levels were calculated relatively to the basal expres-
sion in undifferentiated HF-iPSC (ii). Immunofluorescent staining for cardiac Troponin T (iii). Scale bars: (B and D-i) 100 μm, (D-iii)
50 μm.
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Induced pluripotent stem cells from hair follicles 1374 and alkaline phosphatase (Fig. 2B). Of note, transgene ex-
pression was found to be efficiently silenced (Suppl. Fig.
1A). HF-iPSC lines were analyzed in the PluriTest assay, a
novel bioinformatic assay for pluripotency, which eliminates
the need of animal use for teratoma assay (Müller et al.,
2011). Both HF-iPSC lines displayed high Pluripotency
Scores, similar to hES and fibroblast-derived iPSC (Fig. 2C).
HF-iPSC lines scored relatively high on PluriTest's Novelty
Score, a metric that measures the divergence of the global
stem cell transcriptome from expected patterns present in
well-characterized iPSC and hES. This result suggests that
HF-iPSC, while being genetically normal as demonstrated
by karyotypic analysis (Suppl. Fig. 1B), might display a dis-
tinct signature, possibly due ‘epigenetic memory’ stemming
from their ectodermal origin.
HF-iPSC pluripotency was further demonstrated by their
in vitro ability to form embryoid bodies (EB) and to differen-
tiate into the three embryonic germ layers endoderm (shown
by the expression of alpha-fetoprotein (AFP)), mesoderm
(CD31) and ectoderm (cytokeratin K14) (Fig. 2D). Spontane-
ous contraction was observed indicating cardiac commit-
ment (data not shown), which was further confirmed by
Troponin T (cardiac marker) positive cells (Fig. 2D).
Characterized pluripotent HF-iPSC were further differen-
tiated into neuronal cells. During the last decade, studies on
hES have reported numerous protocols for neuronal differen-
tiation, leading to the production of homogenous and spe-
cialized neurons, capable of basic neuronal activities in
vitro and upon transplantation in animal models. We evalu-
ated the neural potential of HF-iPSC to form two types of
multipotent progenitors, either anterior neuroectodermal
Pax6+ cells or floor plate FoxA2+ cells. The two HF-iPSC
lines spontaneously formed rosette structures that con-
tained Pax6+/nestin+ neural progenitor cells upon culturing
them on MS-5 stroma cells in absence of morphogens
(Fig. 3A-a). Moreover, HF-iPSC were also differentiated
into floor plate FOXA2+ progenitors, a newly described type
of neural precursors (Fasano et al., 2010) (Fig. 3A-b). Quan-
tification by flow cytometry showed that 89% of the cells
were FOXA2+ (Fig. 3A-c). In order to fully evaluate the neu-
ronal potential of HF-iPSC, we directed the HF-iPSC to two
types of mature neurons, dopaminergic neurons or forebrain
neurons, which are involved in various neurological disor-
ders. HF-iPSC were differentiated towards mature βIII-
tubulin+ TH+ dopaminergic neurons by SMAD inhibition pro-
tocol (Chambers et al., 2009) (Fig. 3B-a). Quantification by
flow cytometry showed that 75% of the cells are βIII-
tubulin+ (Fig.3B-b). HPLC analysis of the extracellular medi-
um of these differentiated neural cells revealed the pres-
ence of both dopamine and serotonin, and their respective
metabolites homovanillic acid (HVA) and 5-
hydroxyindolacetic acid (5HIAA) (Fig. 3B-c), while they
were undetected in undifferentiated HF-iPSC (data not
shown). This further supports the presence of functional do-
paminergic and serotonergic neural cells in our differentiat-
ed culture. In parallel, HF-iPSC could also be differentiated
towards βIII-tubulin+/TBR1+ forebrain glutamatergic neu-
rons by prolonged spontaneous EB differentiation (Fig. 3C).
Human iPSC lines are usually produced from fibroblasts
isolated from skin biopsies, a traumatic invasive procedure
demanding local anesthesia and medical follow-up. Hair fol-
licle (HF) plucking, however, is simple, painless and a non-invasive alternative procedure. In the genuine study demon-
strating that skin keratinocytes can produce iPSC, HF has
been suggested as an alternative source for cell reprogram-
ming (Aasen et al., 2008) and our study confirms that as
few as ten HF in anagen phase can be used to successfully re-
program keratinocytes into iPSC and shows that HF-iPSC can
serve as an efficient model to obtain various types of donor-
specific neuronal lineages. An additional advantage of HF,
demonstrated in the present study, is the ability to store
plucked HF in medium for at least 48 h at room temperature,
allowing exchange of materials between clinical centers and
research laboratories. Taken together, these advantages
suggest hair follicles as a material of choice for deriving of
iPSC lines from a relatively large sample size of patients suf-
fering from neuropsychiatric disorders. Moreover, the HF-
keratinocytes, similar to neurons are derived from the
same ectodermal embryonic layer, and thus, besides carry-
ing an identical genetic load, could retain the same epige-
netic alterations during early development. Indeed, it has
been demonstrated that iPSC can retain epigenetic memory
of the tissue of origin (Kim et al., 2010). It is therefore con-
ceivable that iPSC derived from HF keratinocytes would re-
tain conserved epigenetic insults that occurred during
embryonic neuroectodermal fate in patients, which will en-
able studying epigenetic factors during normal and patholog-
ical neurodevelopment in vitro.
One can argue that multifactorial pathologies are difficult
to model with iPSC due to the heterogeneity of the genetic
background and environmental factors involved in their etiolo-
gy. Nevertheless, a recent study revealed abnormal neuronal
connectivity in schizophrenic patient-derived iPSC, demon-
strating the relevance of this approach (Brennand et al.,
2011). In their study, commercially available skin-derived fi-
broblasts were used. However, the compliance of patients to
skin biopsy is rather low and therefore hair follicles are an at-
tractive and painless alternative to obtain large number of
iPSC lines-and their derived neurons. Indeed, we have already
produced iPSC lines from four schizophrenic patients with sim-
ilar efficiency to that of healthy donors (data not shown). We
believe that HF-iPSC-based models will facilitate the biological
research of complex neurodevelopmental disorders and may
provide new insights into neuron development in health and
disease. In addition HF-iPSC may serve as a tool for the design
of alternative therapeutics and for personalized pharmaco-
genetic studies to optimize drug therapy for the benefit of
the patients.
In summary, this study illustrates the use of hair follicles
as an easy source of reprogrammable cells to produce
patient-specific neurons. HF-iPSC can differentiate into dif-
ferent types of functional neuronal cells and therefore
could be a material of choice to model psychiatric, neurode-
velopmental disorders.Materials and methods
Hair follicle keratinocyte culture
Samples collection from two healthy individuals was ap-
proved by The Rambam Medical Center Institutional Review
Board Hair follicles in anagen phase (5–15) were plucked
and washed twice in DMEM supplemented with penicillin,
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Figure 3 Differentiation of HF-iPSC into neuronal cells. (A) HF-iPSC lines differentiated into neural progenitors: (a) Pax6 +nestin +
progenitors on MS-5 feeders (b) FoxA2 +nestin + floor plate progenitors by direct differentiation. (c) Quantification of FoxA2+ cells by
flow cytometry. Cells incubated with secondary antibody only were used for gating positive cells. (B) HF-iPSC lines differentiated into
mature dopaminergic neurons: (a) Dopaminergic βIIItubulin +TH +neurons obtained by SMAD inhibition protocol (b) Quantification of
βIIItubulin +neurons by flow cytometry. Cells incubated with secondary antibody only were used for gating positive cells. (c) Extracel-
lular dopamine (DA) and serotonin (5-HT) and their metabolites HVA and 5HIAA, respectively, in differentiated neurons analyzed by
HPLC. Plain medium and undifferentiated HF-iPSC were also tested as controls and none of these molecules could be detected. (C)
HF-iPSC lines differentiated into mature forebrain glutamatergic βIIItubulin +TBR1+ neurons by spontaneous differentiation of embry-
oid bodies. Scale bars: (A-phase) 100 μm, (A-inset, A-b, B-a, and C) 50 μm.
138 I. Petit et al.streptomycin, anti-fungal nystatin and anti-mycoplasma Bio-
myc (Biological Industries, Bet Haemek, Israel). The extrem-
ities containing outer root sheath (ORS) were cut and placed in
0.25% trypsin/EDTA 3–4 times for 20 min each round. Between
each round of trypsin, follicles were vigorously triturated by up
and down aspiration. Complete dissociation of outer root
sheath cells was monitored under microscope. Cells were
washed and seeded on mitomycin C-inactivated 3T3-G2 fibro-
blast feeders in keratinocyte medium (DMEM:F12 3:1 supple-
mented with 10% FCS (FcII, Hyclone, Thermo, Waltham, MA,
USA), 1 mM glutamine (Biological Industries), 1 mM NaPyruvate
(Biological Industries), 0.2 mM adenine (Sigma-Aldrich, St
Louis, MO, USA), 5 μg/ml insulin (Sigma), 0.5 μg/ml hydrocorti-
sone (Sigma), 2 nM triiodothyronine (Sigma), 0.1 nM cholera
toxin (sigma) and 10 ng/ml EGF (Peprotech, Rocky Hill, NJ,
USA)). HF keratinocytes could be amplified for 4–5 passages
and frozen down at early passages.Reprogramming of keratinocytes into iPSC
HF keratinocytes at early passages (1–2) were seeded in 6-
well on 3T3-G2 feeders 2–3 days before infection. Lentiviral
preparation was made freshly for each experiment, by trans-
fection of 293FT cells (Invitrogen, Carlsbad, CA, USA) with
the human STEMCCA plasmid (Somers et al., 2010) using Jet-
PEI reagent (PolyPlus-transfection, Illkirch, France). Cells
were infected with lentiviral supernatant for 7 h and
replaced with fresh medium (Day 0). Infection was repeated
on the next day. Three days later (Day 4) keratinocytes were
seeded on mitomycin-treated MEFs in keratinocyte medium.
On day 7 medium was switched to 50% Green medium/50%
iPSC medium (DMEM/F12, 20% knockout serum replacement
(Invitrogen), 1 mM glutamine, 100 μM non-essential amino-
acids (Biological Industries), 100 μM beta-mercaptoethanol
(Invitrogen), 10 ng/ml bFGF (Peprotech)). On day 10 medium
Induced pluripotent stem cells from hair follicles 139was switched to 100% iPSC medium. The following inhibitors
were added from days 8–9 to day 20: 2 μM SB431542 (Sigma),
3 μM CHIR99021 (AxonMedchem, Groningen, the Netherlands),
3 μM Parnate (P8511, Sigma) and 5 μM PS48 (Stemgent, Cam-
bridge, MA, USA). Colonies with hES morphology were picked
between days 20–40 and expanded individually.
Pluripotency characterization
Expression of pluripotency markers was determined by im-
munofluorescence using TRA-1-81 (Santa Cruz Biotechnolo-
gy, Santa Cruz, CA) and SSEA-4 (R&D Systems, Minneapolis,
MN) antibodies and by quantitative real-time PCR (qRT-
PCR) using Aurum RNAkit (Biorad, Hercules, CA, USA) for
RNA isolation, iScript kit (Biorad) for single strand cDNA syn-
thesis and SYBR SensiMix (Bioline, London, UK) for qRT-PCR.
Alkaline phosphatase activity was revealed by incubation
with 0.01% Naphtol (Sigma) and 0.5 mg/ml Fast Blue
(Sigma) in 100 mM Tris–HCl and 20 mM MgCl2.
For whole genome microarray profiling, RNA was isolated
from two biological replicates per cell line (1×106 cells per
sample) with the mirVana RNA isolation kit (Ambion, Carlsbad,
USA). Illumina HT12v3 microarrays were hybridized following
the manufacturers instructions and as previously described
(Müller et al., 2011). The resulting raw data was processed
with the PluriTest algorithm (Müller et al., 2011) for testing
pluripotent features in keratinocytes and iPSC lines. Genetic in-
tegrity was evaluated by G-banded karyotype analysis.
Spontaneous differentiation
iPSC colonies were cultured in suspension in petri dish in differ-
entiation medium (DMEM supplemented with 10% FBS, 1 mM
glutamine,100 μM non-essential amino-acids, 100 μM beta-
mercaptoethanol) to allow the formation of embryoid bodies
(EBs). EBs were plated on days 7–8 on gelatin-coated plates
and further cultured until day 21. Paraformaldehyde-fixed
cells were stained for Troponin T (Thermo Ficher scientific,
Waltham, MA). The expression of CD31, K14 and AFP was ana-
lyzed by quantitative real-time PCR (qRT-PCR) as detailed
above.
Neuronal differentiation
For neuronal rosette induction, iPSC colonies were seeded on
mitomycin-treated MS-5 feeder in DMEM/F12 supplemented
with 15% knockout serum replacement, 1 mM glutamine,
100 μM non-essential amino-acids and 100 μM beta-
mercaptoethanol for 15–18 days. Floor plate FOXA2+ progeni-
tors were obtained by direct induction according to Fasano et
al. (Fasano et al., 2010). Briefly, iPSC were treated with accu-
tase (Sigma) and plated on matrigel (BD biosciences, Franklin
Lakes, NJ) with MEFs-conditioned iPSC medium for 2 days in
the presence of Y-27632 (10 μM). bFGF was removed on day
0. KSR was gradually decreased from 20% to 15% on day 5, 10%
on day 7, 5% on day 9 while N2 supplement (Invitrogen) was
gradually added from 0% to 1% on same days. Neural commit-
ment was induced by Noggin (R&D Systems, 500 ng/ml),
SB431542 (Sigma, 10 μM) on days 0–11, SHH-C24-II (R&D Sys-
tems, 200 ng/ml) and Wnt1 (Peprotech, 50 ng/ml) on days
1–11, FGF8 (R&D Systems, 100 ng/ml) was added on days 9–11.Dopaminergic neurons were obtained as previously de-
scribed (Chambers et al., 2009). Briefly, iPSC were plated as
described above for floor plate progenitors and the same
KSR/N2 medium was used. Noggin (R&D Systems, 500 ng/ml)
and SB431542 (10 μM) were added on days 0–12, SHH
(200 ng/ml) was added on days 5–12, FGF8 (100 ng/ml),
BDNF (R&D Systems, 20 ng/ml) and ascorbic acid (AA,
0.2 mM) on days 9–12. After splitting, cells were cultured
with N2 supplement, BDNF, AA, GDNF (20 ng/ml), TGFβ3
(R&D Systems, 1 ng/ml) and cAMP (Sigma, 1 mM) until day 20.
Forebrain neurons were obtained after plating EBs as pre-
viously described (Zeng et al., 2010). Briefly, EBs were cul-
tured in suspension in differentiation medium (as described
above) for 4 days then in neural medium consisting of
DMEM/F12 (1:1), 20% N2 supplement (Invitrogen), and
2 μg/ml heparin (Sigma) for 2 more days. EBs were seeded
on gelatin coated well, and culture prolonged to 5–6 weeks
until neural cells were appeared.
PFA-fixed cultures were stained with Pax6, nestin, βIII-
tubulin, TH, TBR1 (all from Chemicon (Millipore), Billerica,
MA, USA) and FOXA2 (Thermo Ficher scientific) antibodies.
Flow cytometry was performed on neural progenitors and do-
paminergic neurons. Cells were fixed with 2% PFA and per-
meabilized with 90% methanol for 30 min on ice. Cells were
incubated in 2% donkey serum/2% BSA with FOXA2 or βIII-
tubulin primary antibody for 60 min, washed with PBS and in-
cubated with secondary antibody (anti-rabbit or -mouse Alexa
Fluor 488, Invitrogen) for 40 min. Cells incubated only with
secondary antibody were used as negative control and refer-
ence to gate positive cells. Acquisition was performed on
FACSCalibur using CellQuest software (BD Biosciences).
Extra-cellular levels of dopamine and
its metabolites
Dopamine (DA) and its metabolite homovanillic acid (HVA) as
well as serotonin (5-HT) and its metabolite 5-
hydroxyindolacetic acid (5-HIAA) were measured in culture
medium by HPLC with an electrochemical detector (ESA cou-
lochem II model 5200, ESA Inc. MA, USA) as described previ-
ously (Ben-Shachar et al., 1997). Separation of the
monoamines and their metabolites was achieved using an
Inertsil ODS-2 column (GL Sciences, Japan) with a mobile
phase composed of 0.1 M NaH2PO4, 0.27 mM Na2EDTA,
1 mM octane sulfuric acid, 4.5% acetonitrile, 2.5% methanol
(pH=2.75). Column eluates were initially oxidized at a po-
tential of +300 mV using an ESA guard cell placed before
the detector, reduced to +100 mV at detector 1 of the ana-
lytical cell (ESA model 5010), and measured at −400 mV at
detector 2. The limit of detection for was 0.01 pmol. Data
were analyzed using Borwin software.
Supplementary materials related to this article can be
found online at doi:10.1016/j.scr.2011.09.003
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